Related Experiment Videos
Antimicrobial activity of polycationic peptides
A Giacometti1, O Cirioni, F Barchiesi
1Institute of Infectious Diseases and Public Health, University of Ancona, Italy. cmalinf@popcsi.unian.it
Abstract:
The in vitro activity of six polycationic peptides, buforin II, cecropin P1, indolicidin, magainin II, nisin, and ranalexin, were evaluated against several clinical isolates of gram-positive and gram-negative aerobic bacteria, yeasts, Pneumocystis carinii and Cryptosporidium parvum, by using microbroth dilution methods. The peptides exhibited different antibacterial activities and rapid time-dependent killing. The gram-negative organisms were more susceptible to buforin II and cecropin P1, whereas buforin II and ranalexin were the most active compounds against the gram-positive strains. Similarly, ranalexin showed the highest activity against Candida spp., whereas magainin II exerted the highest anticryptococcal activity. Finally, the peptides showed high anti-Pneumocystis activity, whereas no compound had strong inhibitory effect on C. parvum.
Insights
Six polycationic peptides show potent antimicrobial activity against various pathogens. These peptides demonstrate rapid, time-dependent killing, with varying efficacy against gram-positive bacteria, gram-negative bacteria, yeasts, and Pneumocystis carinii.
Area of Science:
- Antimicrobial Peptides
- Microbiology
- Infectious Diseases
Background:
- Polycationic peptides are a class of antimicrobial agents with broad-spectrum activity.
- Understanding the specific activity profiles of different peptides is crucial for therapeutic development.
- Clinical isolates present a relevant model for evaluating antimicrobial efficacy.
Purpose of the Study:
- To evaluate the in vitro antimicrobial activity of six polycationic peptides: buforin II, cecropin P1, indolicidin, magainin II, nisin, and ranalexin.
- To determine the efficacy of these peptides against a range of clinical isolates, including bacteria, yeasts, Pneumocystis carinii, and Cryptosporidium parvum.
- To characterize the killing kinetics and spectrum of activity for each peptide.
Main Methods:
- Microbroth dilution assays were employed to determine the minimum inhibitory concentrations (MICs) of the peptides.
- The study utilized clinical isolates of gram-positive and gram-negative aerobic bacteria.
- Evaluations included activity against yeasts (Candida spp.), Pneumocystis carinii, and Cryptosporidium parvum.
Main Results:
- Peptides displayed differential antimicrobial activities and rapid, time-dependent killing kinetics.
- Buforin II and cecropin P1 were most effective against gram-negative bacteria.
- Buforin II and ranalexin showed highest activity against gram-positive strains; ranalexin was most potent against Candida spp.; magainin II excelled against Pneumocystis carinii.
Conclusions:
- Polycationic peptides exhibit significant in vitro activity against a variety of microbial pathogens.
- The study highlights the distinct antimicrobial profiles of individual peptides, suggesting potential for targeted applications.
- While effective against bacteria, yeasts, and Pneumocystis, these peptides showed limited activity against Cryptosporidium parvum.